| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8227383 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
No differences were seen in the rates of LR or AF between N- and N+ patients after APBI. These results support the continued enrollment of node-positive patients in Phase III trials evaluating the efficacy of APBI including the National Surgical Adjuvant Breast and Bowel Project-B39/Radiation Therapy Oncology Group 0413.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chirag M.D., J. Ben M.D., Simona M.D., Inga S. M.D., Peter Y. M.D., Nayana M.D., Ishmael D.O., Michelle R.N., Christina K. R.N., Frank A. M.D.,